Mostrando 5 resultados de: 5
Filtros aplicados
Subtipo de publicación
Article(5)
Área temáticas
Enfermedades(4)
Medicina forense; incidencia de enfermedades(2)
Medicina y salud(2)
Farmacología y terapéutica(1)
Fisiología humana(1)
Origen
scopus(5)
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
ArticleAbstract: The trajectories of acquired immunity to severe acute respiratory syndrome coronavirus 2 infection aPalabras claves:Autores:Abuelgasim H., Adland E., Alexander F., Alhussni A., Ali M., Allott K., Arancibia-Cárcamo C.V., Azim Ansari M., Belij-Rammerstorfer S., Bibi S., Blackwell L., Borak M., Brown A., Brown H., Cassar M.P., Cavell B., Clutterbuck E.A., Conlon C.P., Cutteridge J., de Silva T.I., Deeks A.S., Denly L., Dimitriadis S., Dong T., Duncan C.J.A., Eyre D.W., Fassih S., Flaxman A., Foord T., Fordwoh T., Frater J., Fries A., Goulder P., Grist J., Hackstein C.P., Halkerston R., Harding A.C., Hill J., Ho L.P., Holmes J., Horsington B., James T., Javier Gilbert Jaramillo, Jay C., Jeffery K., Johnson S.A., Kerneis S., Kim D., Knight J.C., Kronsteiner B., Lambe T., Lie Y., Lillie K., Linder A., Longet S., Lumley S.F., Marinou S., Matthews P.C., Mellors J., Mentzer A.J., Moore S.C., Morrow J., Neubauer S., Ogbe A., O’Connor D., O’Donnell D., Pace M., Payne R.P., Peng Y., Petousi N., Petropoulos C., Pollard A.J., Raman B., Richter A., Ritter T.G., Rongkard P., Rowland-Jones S.L., Sedik C., Silva-Reyes L., Simmons B., Skelly D.T., Smith H., Stafford L., Stockdale L., Talbot N.P., Taylor A., Taylor S., Thomas S., Thomas S.R., Tipoe T., Tomic A., Travis S., Turtle L., Vieira V.A., Warren Y., Watson A.J.R., Weeks E., Wilson R., Wrin T., Young R.Fuentes:scopusTwo doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
ArticleAbstract: The extent to which immune responses to natural infection with severe acute respiratory syndrome corPalabras claves:Autores:Abuelgasim H., Adele S., Adland E., Adlou S., Alhussni A., Ali M., Amini A., Barnes E., Blackwell L., Bridges-Webb A., Brown A., Brown H., Camara S., Carroll M.W., Cassar M.P., Chinnakannan S., Conlon C.P., Csala A., Cutteridge J., de Lara C., de Oliveira T., de Silva T.I., Deeks A.S., Denly L., Dimitriadis S., Dold C., Dong T., Donnison T., Dunachie S.J., Duncan C.J.A., Edmans M., Frater J., Fries A., Goulder P., Hackstein C.P., Harding A.C., Hill J., Ho L.P., Holmes J., Huang K.Y.A., Hutchings C.L., James W.S., Javier Gilbert Jaramillo, Jay C., Jeffery K., Johnson S.A., Kasanyinga M., Kerneis S., Klenerman P., Knight J.C., Knight M.L., Lee L.N., Li W., Lillie K., Linder A., Longet S., Malone T., Marinou S., Marjot T., Matthews P.C., Mehta H., Mentzer A.J., Moore S.C., Neubauer S., Ogbe A., O’Donnell D., Pace M., Payne R.P., Peng Y., Petousi N., Phalora P., Phillips E., Pollard A.J., Raman B., Richter A., Rijal P., Robinson N., Rongkard P., Schimanski L., Sigal A., Silva-Reyes L., Simmons B., Skelly D.T., Stafford L., Talbot N.P., Tan T.K., Thomas S.R., Tipoe T., Tipton T., Townsend A.R., Turtle L., Watson A.J.R., Weeks E., Wilson R., Zacharopoulou P.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopusSARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
ArticleAbstract: Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response toPalabras claves:Autores:Abraham P., Adams H., Adele S., Afifi S., Asamaphan P., Ash A., Ashraf S., Austin J.A., Azim Ansari M., Barnes E., Barrow M., Beckwith S.M., Beer R., Bernardo M. Gutierrez, Bonsall D., Bresner C., Brown A., Buchan S.L., Cantoni D., Connor T.R., Cowton V., Curran T., Cutino-Moguel T., da Silva Filipe A., Davis C., De Lorenzo G., de Silva T.I., Deeks A.S., Dunachie S.J., Duncan C.J.A., Edgeworth J., Fairley D.J., Fraser C., Fryer H., Fuller W., Furnon W., Golubchik T., Grove J., Guest M., Gunson R., Harvey W.T., Holden M.T.G., Holland P., Hughes J., John M., Jones O., Kele B., Kitchen C., Klenerman P., Koshy C., Kronsteiner B., Logan N., Lythgoe K., Mack A., MacLean O.A., Maksimovic J., Manali M., Mantzouratou A., Marchbank A., McCluggage K., McKenna J.P., Merrick I., Moore S.C., Morgan S., Morriss A., Munn R., Murcia P.R., Murray A., Murray S.M., Nebbia G., Orton R.J., Pascall D.J., Patel A., Patel A.H., Patel B., Payne R.P., Pinto R.M., Price A., Puxty K., Reynolds N., Richter A., Scott S., Shaaban S., Silva V., Singleton D., Smollett K., Southgate J., Spellman K., Szemiel A., Templeton K.E., Thomson L., Tong L., Turtle L., Vink E., Warne B., Whalley T., Wilkie C., Willett B.J., Workman T., Yebra G.Fuentes:scopusSARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2
ArticleAbstract: Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in tPalabras claves:covid-19, Delta variant, GENETIC DIVERSITY, mutation, SARS-COV-2, Transmission advantageAutores:Aanensen D.M., Aggarwal D., Amato R., Ariani C.V., Atchison C., Barrett J.C., Bashton M., Beckett A.H., Beckwith S.M., Bernardo M. Gutierrez, Bodinier B., Bonsall D., Bucca G., Bull M., Burns P.J., Byott M., Carabelli A.M., Chand M., Connor T.R., Corden S., Cortes N., Cottrell S., Curran M.D., Darby A.C., De Angelis D., de Oliveira Martins L., de Silva T.I., Eales O., Eastick K., Fairley D.J., Frampton D., Glaysher S., Golubchik T., Goncalves S., Goodfellow I.G., Gunson R.N., Gupta R.K., Hamilton W.L., Harrison E.M., Hassan-Ibrahim M.O., Haw D., Holden M.T.G., Houlihan C., Jackson D.K., Jackson L.M., Johnston I., Jonnerby J., Kwiatkowski D.P., Langford C.F., Levett L.J., Liggett S., Lillie P.J., Livett R., Loman N.J., Loose M.W., Loveson K.F., Ludden C., Lythgoe K., Mahungu T.W., Moore C., Moore N., Moses S., Murray A., Nastouli E., Nebbia G., Nicholls S.M., Nunez R.T.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Parker M.D., Parmar S., Paterson S., Pope C.F., Prieto J.A., Pybus O.G., Rambaut A., Randell P., Robson S.C., Rogan F., Saeed K., Shepherd J.G., Sheridan L.A., Sillitoe J., Simpson D.A., Singleton D., Smith C.P., Smith D.L., Snell L.B., Templeton K.E., Thomas C., Thomson E.C., Torok M.E., Underwood A.P., Volz E.M., Wang D., Wang H., Watkins J., Williams C., Witney A.A.Fuentes:scopus